Bedside evaluation of cardiac markers: Point-of-care testing can differentiate acute coronary syndromes

Postgraduate Medicine

Volumn 118, Issue 3, 2005, Pages 15-22

  Amsterdam, Ezra A ^a,d   Deedwania, Prakash ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; CLINICAL EXAMINATION; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ELECTROCARDIOGRAPHY; HEART INDEX; HEART MUSCLE REPERFUSION; HUMAN; RISK ASSESSMENT; TURNAROUND TIME; BLOOD; HEART INFARCTION; HOSPITAL INFORMATION SYSTEM; REVIEW; SENSITIVITY AND SPECIFICITY; UNSTABLE ANGINA PECTORIS;

BIOLOGICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; ISOENZYME; MYOGLOBIN; TROPONIN;

ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CREATINE KINASE; CREATINE KINASE, MB FORM; ELECTROCARDIOGRAPHY; HUMANS; ISOENZYMES; MYOCARDIAL INFARCTION; MYOGLOBIN; POINT-OF-CARE SYSTEMS; SENSITIVITY AND SPECIFICITY; TROPONIN;

EID: 26944491882     PISSN: 00325481     EISSN: 12182583     Source Type: Journal    
DOI: 10.3810/pgm.2005.09.1703     Document Type: Conference Paper

References (29)

1. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Accessed Jul 27, 2005
2. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1,000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 1994;343(8893):311-22
3. [Erratum, Lancet 1994;343(8899):742]
4. Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36(3):959-69
5. [Erratum, J Am Coll Cardiol 2001;37(3):973]
6. Jeremias A, Gibson CM. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 2005;142(9):786-91
7. Yusuf S, Zhao F, Mehta SR, et al; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345(7):494-502
8. Errata, N Engl J Med 2001;345(23):1716
9. and N Engl J Med 2001;345(20):1506
10. Pope JH, Aufderheide TP, Ruthazer R, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000;342(16):1163-70
11. Amsterdam EA, Kirk JD, Diercks DB, et al. Early exercise testing in the management of low risk patients in chest pain centers. Prog Cardiovasc Dis 2004;46(5):438-52
12. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines. Circulation 2004;110(9):e82-292. Accessed Jul 27, 2005
13. Storrow AB. National Academy of Clinical Biochemistry 2004 Recommendations - biomarkers of acute coronary syndrome and heart failure. Accessed Jul 8, 2005
14. Altinier S, Zaninotto M, Mion M, et al. Point-of-care testing of cardiac markers: results from an experience in an emergency department. Clin Chim Acta 2001;311(1):67-72
15. Azzazy HM, Christenson RH. Cardiac markers of acute coronary syndromes: Is there a case for point-of-care testing? Clin Biochem 2002;35(1):13-27
16. Wu AH, Smith A, Christenson RH, et al. Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction. Clin Chim Acta 2004;346(2):211-9
17. Kost GJ, Tran NK. Point-of-care testing and cardiac biomarkers: the standard of care and vision for chest pain centers. Cardiol Clin 2005 (in press)
18. Kost GJ, Ehrmeyer SS, Chernow B, et al. The laboratory-clinical interface: point-of-care testing. Chest 1999;115(4):1140-54
19. Gibler WB, Lewis LM, Erb RE, et al. Early detection of acute myocardial infarction in patients presenting with chest pain and nondiagnostic ECGs: serial CK-MB sampling in the emergency department. Ann Emerg Med 1990;19(12):1359-66
20. [Erratum, Ann Emerg Med 1991;20(4):420]
21. Hamm CW. Cardiac biomarkers for rapid evaluation of chest pain. Circulation 2001;104(13):1454-6
22. Muller-Bardorff M, Rauscher T, Kampmann M, et al. Quantitative bedside assay for cardiac troponin T: a complementary method to centralized laboratory testing. Clin Chem 1999;45(7):1002-8
23. Alp NJ, Bell JA, Shahi M. A rapid troponin-I-based protocol for assessing acute chest pain. QJM 2001;94(12):687-94
24. Ambrose TM, Knight D, Neher J. The cardiac reader: a platform for quantitative point-of-care cardiac marker determinations from Roche Diagnostics. Point Care 2002;1(1):50-3
25. Gaze D, Collinson PO, Haass M, et al. The use of a quantitative point-of-care system greatly reduces the turnaround time of cardiac marker determination. Point Care 2004;3(4):156-8
26. Ng SM, Krishnaswamy P, Morissey R, et al. Ninety-minute accelerated critical pathway for chest pain evaluation. Am J Cardiol 2001;88(6):611-7
27. McCord J, Nowak RM, McCullough PA, et al. Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation 2001;104(13):1483-8
28. Newby LK, Storrow AB, Gibler WB, et al. Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study. Circulation 2001;103(14):1832-7
29. Stubbs P, Collinson PO. Point-of-care testing: a cardiologist's view. Clin Chim Acta 2001;311(1):57-61